M4MM

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Audacious Reports Fiscal Q2 2022 Financial Results

LAS VEGAS–Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF), today announced that the Company has filed its financials and management discussion and analysis for its fiscal second quarter of fiscal 2022 (the year ending March 31, ...

Subscribe To Our Newsletter